AB Ovosp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-19
Share capital
400,000.00 PLN
Registered address
ul. Relaksowa 26, 20-819 Lublin, Poland
Electronic delivery address
AE:PL-20025-99867-HEWDD-26

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 331 days for 2024).

  • 2025not filed
  • 202411/06/2026
  • 202315/10/2024
  • 202228/07/2023
  • 202127/12/2022
  • 202002/02/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 2.38mMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD 902.26kMedianUSD 14.31kAverageUSD 129.53k
Operating costs
This companyUSD 1.25mMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 1.53mMedianUSD 173.92kAverageUSD 1.02m

Industry

Trademarks

AB Ovo currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2001.

MarkNumberClassesStatusProtected until
Ab ovo(word)Z.2385415, 10, 35, 42, 44Expired –
MarkProtected until
Ab ovo(word)–

Authorized Representatives

Bartosz Mrugacz – Management Board Member
Grzegorz Mrugacz – President of the Management Board
Krzysztof Mrugacz – Management Board Member

Manner of representation

Each member of the management board has the right to represent the company individually.

Ownership

OwnerSharesShare valueStake
800$108,049.70100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

9 public aid cases recorded, with a total value of $87,233.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$456
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$55,387
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$13,495

European Funds

ProjectEU co-financing
Support for financing working capital in connection with the deterioration of the company's situation as a result of the COVID-19 pandemic
$13,495

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2020-11-05Share capital increase
2019-08-05Address change
2009-05-06Name change
2001-07-19Entered in the register

FAQ

Last updated: 2026-10-07